Global Rapid Influenza Diagnostic Tests Market is Estimated to Witness High Growth Owing to Growing Prevalence of Influenza
Market Overview: Global Rapid Influenza Diagnostic Tests (RIDTs) are immunoassays used for the rapid detection of influenza viruses. They detect influenza viral nucleoprotein antigens in respiratory specimens like nasal swabs. RIDTs provide quick results within 15-30 minutes and are useful for faster clinical diagnosis and treatment decisions. The Global Rapid Influenza Diagnostic Tests Market was valued at US$ US$ 1.29 Billion in 2023 and is expected to exhibit a CAGR of 7.9% over the forecast period 2023 - 2033, as highlighted in a new report published by CoherentMI. Market Dynamics: The Global Rapid Influenza Diagnostic Tests Market Size is estimated for 2023 for the forecast period 2023-2030, as highlighted in a new report published by CoherentMI. The Global Rapid Influenza Diagnostic Tests market is expected to witness significant growth over the forecast period owing to the growing prevalence of influenza. According to the Centers for Disease Control and Prevention...